Tofacitinib in a Recalcitrant Case of Alopecia Areata

    Mansi Pithadia, Jui Shah, Krunal Dudhatra, Kinjal Patel
    TLDR Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.
    This article discusses a case of recalcitrant alopecia areata in a 14-year-old female who was successfully treated with oral tofacitinib. Alopecia areata is a non-cicatricial autoimmune disease characterized by smooth, round patches of hair loss. Tofacitinib is highlighted as a promising therapy for severe cases of alopecia areata, with increasing evidence supporting its efficacy. The case presented adds to the growing body of literature demonstrating the potential of tofacitinib in treating this condition.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 11 results

    Related Research

    3 / 3 results